NCT05988632View on ClinicalTrials.gov

Intranasal Insulin for Treatment of Alcohol Use Disorder

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Alcohol Use Disorder
Interventions
DRUG

Regular Human Insulin then Placebo

Insulin: 80 IU (administered intranasally) THEN Placebo: 0.9% saline solution (administered intranasally)

DRUG

Placebo then Regular Human Insulin

Placebo: 0.9% saline solution (administered intranasally) THEN Insulin: 80 IU (administered intranasally)

Trial Locations (1)

02903

RECRUITING

Brown University, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
lead

Brown University

OTHER

NCT05988632 - Intranasal Insulin for Treatment of Alcohol Use Disorder | Biotech Hunter | Biotech Hunter